Tryp Therapeutics Buy Hold or Sell Recommendation
| TRYPFDelisted Stock | USD 0.05 0 6.89% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Tryp Therapeutics is 'Not Rated'. Macroaxis provides Tryp Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TRYPF positions.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. Note, we conduct extensive research on individual companies such as Tryp and provide practical buy, sell, or hold advice based on investors' constraints. Tryp Therapeutics. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Tryp |
Execute Tryp Therapeutics Buy or Sell Advice
The Tryp recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Tryp Therapeutics. Macroaxis does not own or have any residual interests in Tryp Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Tryp Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Tryp Therapeutics Trading Alerts and Improvement Suggestions
| Tryp Therapeutics is not yet fully synchronised with the market data | |
| Tryp Therapeutics has some characteristics of a very speculative penny stock | |
| Tryp Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7.49 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tryp Therapeutics has accumulated about 2.85 M in cash with (5.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 47.0% of the company outstanding shares are owned by corporate insiders |
Tryp Therapeutics Returns Distribution Density
The distribution of Tryp Therapeutics' historical returns is an attempt to chart the uncertainty of Tryp Therapeutics' future price movements. The chart of the probability distribution of Tryp Therapeutics daily returns describes the distribution of returns around its average expected value. We use Tryp Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Tryp Therapeutics returns is essential to provide solid investment advice for Tryp Therapeutics.
| Mean Return | 0.95 | Value At Risk | -21.87 | Potential Upside | 22.17 | Standard Deviation | 13.04 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Tryp Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Tryp Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Tryp . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Tryp Therapeutics Buy or Sell Advice
When is the right time to buy or sell Tryp Therapeutics? Buying financial instruments such as Tryp OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Tryp Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Agriculture Thematic Idea Now
Agriculture
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Agriculture theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Agriculture Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Tryp OTC Stock
If you are still planning to invest in Tryp Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tryp Therapeutics' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |